Covishield Side Effects are a major concern for many in India. However, a leading scientist is urging people not to let this fear prevent them from getting vaccinated.
Overcoming Vaccine Hesitancy with Covishield
Dr. Raman Gangakhedkar, a former scientist at the Indian Council of Medical Research (ICMR), says that Covishield’s side effects are extremely rare. Out of 100,000 people vaccinated, only 7 or 8 might experience a specific side effect called Thrombosis Thrombocytopenia Syndrome (TTS).
Vaccines and Side Effects: Understanding the Risk
The risk of Covishield side effects is even lower with the second dose and disappears almost entirely by the third dose. If side effects do occur, they are most likely to happen within a few months of vaccination.
Addressing Concerns About the British Court Case
Recent concerns about Covishield safety stem from a British court case where AstraZeneca, the manufacturer of Covishield, acknowledged a rare possibility of blood clotting. This news caused some worry in India, but Dr. Gangakhedkar assures us that the benefits of vaccination far outweigh the risks.
Covishield’s Importance in India’s Vaccination Drive
Covishield is the primary vaccine used in India, with around 90% of the vaccinated population receiving it. This widespread use reflects the trust people have in its safety and effectiveness, a trust that Dr. Gangakhedkar supports with his expertise.
Vaccines and Side Effects: A Balanced Perspective
All vaccines carry a small risk of side effects, but these are usually mild and temporary. Dr. Gangakhedkar reminds us to focus on the vast majority of people who experience no problems after vaccination.
Vaccinate with Confidence
Dr. Gangakhedkar’s message is clear: the benefits of Covishield vaccination far outweigh the minimal risk of side effects. With this knowledge, India can move forward with its vaccination program with renewed confidence.
